We live in an amazing era for medicines. During the past two decades, our industry has discovered life-changing treatments for some of the deadliest diseases. These innovative discoveries have improved the lives of hundreds of millions of people and will continue to benefit many more in the future. However, in order to continue the benefits this era of discovery has provided, we must maintain the environment that fosters innovation and makes these discoveries a reality. This is where trade negotiations come in to level the international playing field and drive innovation by promoting high regulatory and intellectual property (IP) standards and addressing market access barriers. Strong intellectual property standards will help set and enforce the kind of protections that will bolster IP-intensive industries that support jobs across the world. These standards could speed innovation and support global economic growth at a vital time for the world economy.